Bringing advances to the patient bedside
Established in 1984, Baylor Research Institute (BRI) promotes and supports research to bring innovative treatments from the laboratory workbench to the patient bedside. To achieve this bench-to-bedside concept, the institute focuses on basic science, clinical trials, and healthcare effectiveness and quality of care research. Investigators at Baylor are conducting more than 650 active research protocols spanning more than 20 medical specialties.
Baylor Institute for Immunology Research, one component of BRI, is among the top immunological basic science research centers in the world. In 1997, transplant physicians at Baylor successfully performed the world’s first "bridge to transplant" using a genetically altered pig liver. Additionally, president of the Baylor Research Institute and anesthesiologist on staff at Baylor, Michael Ramsay, M.D., developed the most widely used controlled sedation management tool in the international critical care environment.
For more information, please contact Sarah Burdi at 214.820.4721 or Sarah.Burdi@BaylorHealth.edu.